PRIMM Trial (Phone Reminder for IMMunization)

Status Completed

Clinical Trial Summary

The purpose of this study is to determine if in a rural setting of Ondo State, Nigeria, a customized automated telephone and email immunization reminder system will be feasible, acceptable, and significantly improve immunization utilization rates.

Clinical Trial Description

Background: Worldwide, vaccine preventable diseases account for 29% of all deaths between 1 month and 5 years, underscoring the importance of immunizations. In Nigeria, routine childhood immunization rates are unacceptably inconsistent and low, ranging from 35-85% at 14 weeks and 10-37% for all routine immunizations at 12-24 months.

GAP: The feasibility, acceptability and utility of an automated phone immunization reminder system have never been explored in this rural setting of Nigeria.

HYPOTHESIS: Given ~90% of the adult population in Nigeria uses a mobile phone, a customized mHealth immunization reminder system will be feasible and acceptable; and will significantly improve immunization rates in this rural setting of Ondo State, Nigeria.

METHODS: A prospective randomized controlled trial study design will be utilized. This study will recruit parents of healthy newborn infants delivered at Mother and Child Hospital Ondo, who live in Akure or Ondo Town and plan to receive their immunizations at Mother and Child Hospital Ondo.

DATA ANALYSIS: The proportion of immunization visits between intervention and control groups will be compared using a two-sided, two sample test of proportions with p <0.05 being significant. Secondary analysis will focus on the predictive value of social demographic variables on immunization rates. ;

Study Design

Related Conditions & MeSH terms

Immunization

Clinical Trial Details

NCT number	NCT02819895
Study type	Interventional
Source	Children's Hospital of Philadelphia
Contact
Status	Completed
Phase	N/A
Start date	July 2016
Completion date	June 30, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02526394` - Pertussis and Meningitis C Concomitant Vaccination in Adolescents	Phase 4
Completed	`NCT01707212` - Prenatal Education About Infant Immunization Pain Management	Phase 3
Completed	`NCT01463176` - Music Therapy as Procedural Support for Young Children Undergoing Immunizations	N/A
Completed	`NCT01193335` - Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Preterm Compared to Term Infants.	Phase 4
Completed	`NCT04222595` - FluPRINT Study: Characterisation of the Immune and Transcriptional Response to LAIV	N/A
Completed	`NCT05794113` - Comparing the Use of a Mobile App for Surveillance of Adverse Events Following Influenza Immunization to a Web-Based Platform	N/A
Recruiting	`NCT01713322` - Testing Educational Materials in a Paediatric Setting	Phase 3
Not yet recruiting	`NCT03705455` - Immunization Schedule Alert Platform	N/A
Recruiting	`NCT01601197` - A Study of Two Injection Techniques to Reduce Pain in Infants Undergoing Immunization	Phase 3
Completed	`NCT01296906` - Population Versus Practice-based Interventions to Increase Immunizations	N/A
Completed	`NCT01399814` - Restricted Intravenous Fluid Regime Effects on Immunological Indicators of Elderly Patients Operated for Abdominal Cancer	Phase 3
Completed	`NCT01390363` - Study of Adolescent Immunization Recall Systems	N/A
Completed	`NCT02609035` - Immunization Services Model for Adult Rate Improvement	N/A
Recruiting	`NCT02200276` - Influenza Immunization in Adults Over Age 75	N/A
Completed	`NCT01677702` - Study of Yili Lactoferrin ShuHua Milk in the Improvement of Human Immunization	N/A
Recruiting	`NCT05213000` - Adjuvant Effect of Physical Exercise on Immune Response to COVID-19 Vaccination and Interactions With Stress	N/A
Completed	`NCT03188692` - Safety and Efficacy of BK1310 Intramuscular Injection in Healthy Infants	Phase 3
Completed	`NCT02432430` - Comparison of Immunization Quality Improvement Dissemination Study	N/A
Completed	`NCT01379846` - Study of TAK-816 in Healthy Infants	Phase 3
Active, not recruiting	`NCT03943875` - GARDASIL 9: 3 Dose vs. 2 Dose With Delayed 3rd Dose	Phase 4